Philadelphia Chapter In Person Event: Navigating Evolving Topics in Combination Products: Human Factors Considerations, EDDOs, and Post Approval Device Changes

Join us for a panel discussion about the unique considerations that can impact regulatory activities throughout the lifecycle of a combination product with a device constituent part for delivery of a drug or biologics.

Development of a combination product with a device constituent part for delivery of a drug or biologic warrants unique considerations that can impact regulatory activities throughout the total product life cycle.  Join us for a panel discussion with regulatory and technical experts who will discuss topics related to:

  • Essential Drug Delivery Outputs (EDDOs) (FDA Draft Guidance)
  • Use-Related Risk Analyses and Application of Human Factors Engineering Principles for Combination Products (FDA Guidance)
  • Lifecycle Management while navigating changes to the device components after initial marketing authorization in the EU (EMA Q&A)

A set of live demonstrations using a simulated on-body delivery device will also be featured. These live demonstrations will include: a simulated failure of an on-body delivery device, failure analysis of the failed on-body delivery device, MRI compatibility assessment, and a simulated usability study.

Location

Exponent (One uCity Square)
25 N 38th St
Ste. 700
Philadelphia, PA 19104

Cancellations and Refunds

RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.

Substitutions

Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.

Proof of Attendance

A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.

Questions

Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].

Speakers

Heather  Guerin  Ph.D.

Heather Guerin Ph.D.

Global Program Regulatory Director, Novartis

Find out more

Becky Leibowitz Ph.D

Becky Leibowitz Ph.D

Senior Director, CMC Regulatory Affairs, Combination Products, Johnson & Johnson Innovative Medicine

Find out more

Regan Lawson Ph.D.

Regan Lawson Ph.D.

Managing Scientist, Exponent

Find out more

Marta Villarraga Ph.D., RAC (Moderator)

Marta Villarraga Ph.D., RAC (Moderator)

Principal, Exponent

Find out more

Sponsor

 

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.